Jacobs Levy Equity Management, Inc Alnylam Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $16.2 Million - $27.9 Million	-113,084 Reduced 89.49%	13,283 $3.23 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $18.5 Million - $25 Million	126,367 New	126,367 $18.9 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $2.73 Million - $3.84 Million	-22,670 Reduced 72.49%	8,604 $1.26 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $4.64 Million - $6.34 Million	-36,472 Reduced 53.84%	31,274 $5.11 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $10.8 Million - $14.2 Million	67,746 New	67,746 $11.5 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $258,868 - $316,788	-1,525 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $871,725 - $1.2 Million	-6,777 Reduced 81.63%	1,525 $259,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $90,049 - $124,739	-710 Reduced 7.88%	8,302 $1.17 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $277,789 - $332,073	2,259 Added 33.45%	9,012 $1.17 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $818,396 - $1.12 Million	6,753 New	6,753 $983,000
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $7.64 Million - $12.7 Million	-102,590 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $7.27 Million - $9.01 Million	102,590 New	102,590 $8.25 Million

650

109M

1.28M

1.23M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.